We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Vaccine Design and Testing – News and Features

Vaccine vial on ice.

Improving Metabolic Health Before Vaccination Helps Protect Against Influenza

Scientists at St. Jude Children’s Research Hospital have shown that improving metabolic health in obese mice before vaccination, but not after, protects against influenza virus.
An elderly man having a vaccine.

What Happens to the Human Body After 200 Vaccines?

Last month a story about a 62-year-old male made headlines after he claimed to have received 217 vaccines against SARS-CoV-2. Scientists invited the individual for tests to investigate what happens in the body of a hypervaccinated individual.
Strand of orange mRNA on a blue background.
Industry Insight

Harnessing the Therapeutic Potential of Circular RNA

In this interview, Erik Digman Wiklund tells us about the discovery of circRNA and discusses some of the challenges of harnessing its full potential for therapeutic interventions.
A strand of RNA.

Language Model Reads the Genome and Designs More Effective mRNA Vaccines

Language models can be used to home in on partial genome sequences and optimize those sequences to study biology and improve medicine, and have designed more effective mRNA vaccines.
Vaccine vials.

Experimental Pancreatic Cancer Vaccine May Elicit Lasting Immune Response

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with pancreatic cancer.
Syringes on a yellow background.

Melanoma Vaccine Offers Improved Survival for Men

A second-generation melanoma vaccine improves long-term survival, particularly for men, a new study shows.
A needle going into a vaccine vial.

More Broadly Protective Potential Coronavirus Vaccine Developed

The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; however, annually updating those boosters for specific SARS-CoV-2 variants is inefficient for scientists and patients.
A vaccine needle entering a vial.

Patient Who Spontaneously Cleared Hepatitis C Could Inspire Vaccine

By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.
Purple strand of mRNA.
Industry Insight

Creating the Right Environment for mRNA To Thrive

Scott Ripley explores how realizing the potential of mRNA therapeutics will require the standardization of processes, manufacturing agility and collaboration between industry, academia and government bodies.

Close up of a syringe drawing liquid from a vial.

Transformative Technologies in Vaccine Manufacturing

Vaccines are the most cost-effective strategy to prevent and suppress global infections. This article explores innovative strategies and technologies shaping the production of vaccines, ensuring rapid development, scalability and global accessibility.